ECSP12012017A

Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

Abstract

Compounds that inhibit the activity of Bcl-2 or Bcl-XL anti-apoptotic proteins, compositions containing said compounds and methods for treating diseases during which the Bcl-2 anti-apoptotic protein is expressed.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Today

1 priority claim, no other members on record

Priority claims1

Priority claims
DocumentOfficeKindDate
63140409United States of AmericaA